Serviscope's Southard to step down

Article

Serviscope president and CEODonald J. Southard will be leaving the independent service organizationas part of a move to refocus the company's direction. Also leavingthe Wallingford, CT, company is vice president Robert Cate. Serviscope expanded rapidly

Serviscope president and CEODonald J. Southard will be leaving the independent service organizationas part of a move to refocus the company's direction. Also leavingthe Wallingford, CT, company is vice president Robert Cate.

Serviscope expanded rapidly under Southard's tenure but hasconsumed cash almost as quickly, requiring several rounds of privateequity financing. Serviscope hopes that a change at the top willstrengthen the financial management of the company, accordingto Emile Geisenheimer, the company's chairman and a general partnerof Nazem & Co., a venture capital firm that holds a majoritystake in Serviscope.

"The company has grown dramatically over the last severalyears," Geisenheimer said. "Don has done a terrificjob in the sales and marketing arena, but we need to add strengthin (financial management)."

Serviscope has grown from four customers in 1990 to 630 lastyear. The company's revenues have risen accordingly, increasingfrom $100,000 in its first year to $13 million in 1993 (end-September).Serviscope is on a pace to bring in $20 million this year, andthe ISO turned profitable in the first quarter of 1994, accordingto Geisenheimer.

Southard joined Serviscope in 1991 after working for OEMs Philipsand Toshiba (SCAN 12/25/91). He will remain on Serviscope's boardof directors and will provide consulting to the ISO, accordingto Geisenheimer, who is also a former Philips medical executive.

Serviscope is negotiating with an unnamed medical imaging managerto take over the top spot, Geisenheimer said.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.